Pfizer vaccine: Study suggests new risk of deep vein thrombosis | Express.co.uk

AS MANY as 32 million people across the UK will be offered the COVID-19 vaccine in a bid to boost immunity ahead of winter. Although the Pfizer vaccine has proven highly effective at preventing serious illness from COVID-19, a recent study has suggested the jab could carry the rare risk of thrombocy..